Glioblastoma 的个性化治疗:当前状态和未来的前景
Alen Rončević1,2, Nenad Koruga1,2, Anamarija Soldo Koruga2,3
1Department of Neurosurgery, University Hospital Center Osijek, 31000 Osijek, Croatia.
Biomedicines
|June 28, 2023
概括
质母细胞瘤 (GBM) 治疗正在通过个性化医学得到改善. 量身定制的疗法,包括放射治疗和免疫化疗中的AI,显示出在侵略性脑瘤中延长生存的希望.
科学领域:
- 神经瘤学神经瘤学
- 癌症研究 癌症研究
- 医疗技术 医疗技术 医学技术
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
- 目前的标准治疗提供了有限的生存益处,平均寿命为15个月.
- 最大安全的手术切除是最初的步骤,随后是放射治疗和temozolomide化疗.
研究的目的:
- 审查目前对质母细胞瘤的治疗标准.
- 探索新兴的个性化治疗策略.
- 讨论针对GBM患者的新治疗方案.
主要方法:
- 审查目前的质母细胞瘤治疗方案.
- 对神经外科和放射治疗技术进步的分析.
- 对个性化免疫化学疗法的分子标记物的检查.
主要成果:
- 手术的进步提高了瘤切除率.
- 人工智能为个性化放射治疗计划提供了潜力.
- 基因和分子分析可以指导针对患者的免疫化学疗法.
结论:
- 个性化治疗方法对于克服GBM异质性至关重要.
- 个性化治疗有望显著延长患者的生存时间.
- 整合人工智能和分子标记可以彻底改变GBM管理.
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


